Asprin And Statin Use For Management Of Atherosclerotic Cardiovascular Disease In Liver Transplant Candidates: Are We Missing The Mark?
Published 2018 · Medicine
Download PDFAnalyze on Scholarcy
This paper references
Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis
S. Kamal (2017)
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.
Lynn A. Fussner (2015)
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
Arpan Mohanty (2016)
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
S. Singh (2013)
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
J. Berger (2008)
Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample
L. VanWagner (2016)
Why don't physicians follow clinical practice guidelines? A framework for improvement.
M. Cabana (1999)
Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).
K. Rao (2013)
Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations
L. VanWagner (2018)
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).
G. B. J. Mancini (2016)
Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review
A. Francke (2008)
OPTN/SRTR 2013 Annual Data Report: Liver
W. Kim (2015)
Coronary artery disease in decompensated patients undergoing liver transplantation evaluation
S. Patel (2018)
This paper is referenced by
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges
N. S. Samji (2019)